Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1590/S1677-5538.IBJU.2020.1039

Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journal › Editorial › Other › peer-review

Abstract

The review by Gotera that summarized evidences surrounding the available therapeutic agents in patients with coronavirus disease 2019 (COVID-19) is commendable. In addition, the authors listed the possible side effects associated with each of these therapeutic agents, which could serve as a reminder for clinicians who may not be familiar with the safety profile of new or existing but repurposed therapeutic agents for the treatment of COVID-19.

Original language	English
Pages (from-to)	690-691
Number of pages	2
Journal	International Brazilian Journal of Urology
Volume	47
Issue number	3
DOIs	https://doi.org/10.1590/S1677-5538.IBJU.2020.1039
Publication status	Published - May 2021
Externally published	Yes

Access to Document

10.1590/S1677-5538.IBJU.2020.1039Licence: CC BY

346442472-oaFinal published version, 97.9 KBLicence: CC BY

Cite this

@article{1111be944e2a4ffcae527ce661540344,

title = "Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury",

abstract = "The review by Gotera that summarized evidences surrounding the available therapeutic agents in patients with coronavirus disease 2019 (COVID-19) is commendable. In addition, the authors listed the possible side effects associated with each of these therapeutic agents, which could serve as a reminder for clinicians who may not be familiar with the safety profile of new or existing but repurposed therapeutic agents for the treatment of COVID-19.",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2021",

month = may,

doi = "10.1590/S1677-5538.IBJU.2020.1039",

language = "English",

volume = "47",

pages = "690--691",

journal = "International Brazilian Journal of Urology",

issn = "1677-5538",

publisher = "Sociedade Brasileira de Urologia (Brazilian Society of Urology)",

number = "3",

}

TY - JOUR

T1 - Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2021/5

Y1 - 2021/5

N2 - The review by Gotera that summarized evidences surrounding the available therapeutic agents in patients with coronavirus disease 2019 (COVID-19) is commendable. In addition, the authors listed the possible side effects associated with each of these therapeutic agents, which could serve as a reminder for clinicians who may not be familiar with the safety profile of new or existing but repurposed therapeutic agents for the treatment of COVID-19.

AB - The review by Gotera that summarized evidences surrounding the available therapeutic agents in patients with coronavirus disease 2019 (COVID-19) is commendable. In addition, the authors listed the possible side effects associated with each of these therapeutic agents, which could serve as a reminder for clinicians who may not be familiar with the safety profile of new or existing but repurposed therapeutic agents for the treatment of COVID-19.

UR - http://www.scopus.com/inward/record.url?scp=85101897544&partnerID=8YFLogxK

U2 - 10.1590/S1677-5538.IBJU.2020.1039

DO - 10.1590/S1677-5538.IBJU.2020.1039

M3 - Editorial

C2 - 33621028

AN - SCOPUS:85101897544

VL - 47

SP - 690

EP - 691

JO - International Brazilian Journal of Urology

JF - International Brazilian Journal of Urology

SN - 1677-5538

IS - 3

ER -

Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury

Abstract

Access to Document

Other files and links

Cite this